Citi has initiated coverage of EyePoint Pharmaceuticals (NASDAQ:EYPT) with a buy rating, stating it sees the company's drug ...

Citi analysts shared a list of their “most preferred stocks” for 2025. These are “buy” rated stocks they believe investors ...

You can earn 3X points in popular spending categories and get a hefty welcome bonus when you open a new Citi Strata Premier ...

JPMorgan Chase & Co. is leaving a major climate finance group, becoming the latest in a string of Wall Street banks to walk ...

The bank’s departure from the Net Zero Banking Alliance follows the exits of five other major U.S. banks from the climate ...

Nvidia CEO Jensen Huang will deliver the opening keynote at the CES on Monday, with many analysts viewing the event as a ...

Lyft boosted its Citi Bike prices Monday — just as they’re planning to make a killing off of congestion pricing they lobbied ...

BofA analyst Ebrahim Poonawala raised the firm’s price target on Citi (C) to $95 from $90 and keeps a Buy rating on the shares. Despite a 33% ...

Citi lowered the firm’s price target on CRH to $115 from $120 and keeps a Buy rating on the shares. Citi updated estimates ...

Morgan Stanley notes that the firm’s Q4 EPS estimate is median 2% above consensus for the large cap bank group as the firm expects capital ...

The rise in Hyundai India share came after global brokerage firm Citi Research initiated coverage with 'Buy' for target price ...

Citi Wealth unveils new role for fiduciary investment just as JPMorgan's asset management arm welcomes experts to boost ...